Manulife Offloads $3.2B Long-Term Care Risk to Munich Re

  • Manulife closed a reinsurance deal with Munich Re Life US for a block of long-term care policies with C$3.2B in reserves.
  • The transaction, effective July 1, 2026, covers biometric risk at an 80% quota share under IFRS 17 accounting standards.
  • Munich Re Life US is a subsidiary of Munich Re Group, specializing in life and disability reinsurance.

This transaction underscores the growing trend of insurers leveraging reinsurance to manage long-term care risk, particularly as aging populations increase liability exposure. Munich Re's involvement highlights the strategic importance of reinsurers in providing capacity and expertise for complex biometric risks. The deal also reflects broader industry shifts toward capital optimization and risk transfer as insurers navigate evolving regulatory and demographic challenges.

Capital Efficiency
How Manulife will deploy the freed-up capital from this transaction to support growth or shareholder returns.
Regulatory Compliance
Whether the IFRS 17 accounting treatment of this deal will impact Manulife's financial reporting flexibility.
Market Dynamics
The pace at which other insurers follow Manulife's lead in offloading long-term care risk to reinsurers.